tm logo
MEDICABILIS
REGISTERED

on 01 Feb 2022

Last Applicant/ Owned by

BOD AUSTRALIA LIMITED

Level 1377 New South Head RoadDouble Bay 2028New South Wales

AU

Serial Number

1927624 filed on 29th Oct 2018

Registration Number

TMA1118998 registered on 01st Feb 2022

Registration expiry Date

01st Feb 2032

Correspondent Address

560 boul. Crémazie Est3e étageMontréal

QUEBEC

CA

H2P1E8

MEDICABILIS

Trademark usage description

cannabis oils for pharmaceutical and medical purposes; medicinal oils comprising cannabis extracts for pharmaceutical and medical purposes; botanical, Read More

Classification Information


Class [005]
Cannabis oils for pharmaceutical and medical purposes; Medicinal oils comprising cannabis extracts for pharmaceutical and medical purposes; Botanical, herbal, nutraceutical, dietary and nutritional supplements for general health and well-being; Botanical, herbal, nutraceutical, dietary and nutritional preparations containing plant extracts and plant-derived nutrients to reduce stress and fatigue, increase appetite, reduce anxiety, relax tension, mood enhancement and provide an improved sense of well-being; Dietary supplements in the form of powder for general health and well-being; Dietary supplements in the form of capsules for general health and well-being; Dietary supplements in the forms of drop and liquid for general health and well-being; Medical Cannabis, including oils and extracts, pharmaceutical and nutraceutical preparations and pharmaceutical and nutraceutical substances containing plant extracts and plant-derived ingredients for the treatment of metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), Dup15q syndrome, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness, AIDS (HIV) & AIDS wasting, asthma, breathing disorders, hepatitis C, migraines, multiple sclerosis, analgesia, Tourette syndrome, bulimia, psychiatric disorders, namely, bipolar disorder, dementia, anxiety disorders, Alzheimer's disease, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; Medicinal herbs, medicinal oils, medicinal infusions for treating metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), Dup15q syndrome, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and AIDS (HIV) & AIDS wasting, asthma/breathing disorders, hepatitis C, migraines, multiple sclerosis, analgesia, Tourette syndrome, bulimia, psychiatric disorders, namely, bipolar disorder, dementia, anxiety disorders, Alzheimer's disease, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma.


Classification kind code

11

Mark Details


Serial Number

1927624

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 17th Jan 2022
Agent Changed
Submitted for opposition 191
on 04th Aug 2021
Registration Fee Notice Sent
Submitted for opposition 190
on 04th Aug 2021
Registration Pending
Submitted for opposition 42
on 12th May 2021
Advertised
Submitted for opposition 26
on 16th Apr 2021
Approved
Submitted for opposition 27
on 16th Apr 2021
Approval Notice Sent
Submitted for opposition 22
on 12th Apr 2021
Search Recorded
Submitted for opposition 31
on 31st Oct 2018
Formalized
Submitted for opposition 1
on 30th Oct 2018
Created
Submitted for opposition 30
on 29th Oct 2018
Filed